Skip to main content

Vanderbilt Ingram Cancer Center Archives

Funding renewed for Meharry, TSU, Vanderbilt-Ingram partnership on cancer disparities

Sep. 24, 2021—The Meharry Medical College/Vanderbilt-Ingram Cancer Center/Tennessee State University Partnership has received renewed funding from the NCI to continue long-standing collaborations to eliminate cancer health disparities.

Read more


Clinical trial tests ATR inhibitor in difficult-to-treat cancers

Sep. 23, 2021—  by Tom Wilemon A clinical trial has been launched to test a new targeted therapy in patients with advanced and difficult-to-treat cancers. Satya Das, MD, MSCI, assistant professor of Medicine at Vanderbilt-Ingram Cancer Center (VICC), is the national principal investigator for the trial (NCT04514497) that is now enrolling people with metastatic small cell lung...

Read more


Eng named co-chair of NCI clinical trials steering committee

Sep. 23, 2021—Vanderbilt's Cathy Eng, MD, has been elected co-chair of the National Cancer Institute (NCI) Gastrointestinal Cancer Steering Committee.

Read more


Structural variants in breast cancer risk genes

Sep. 16, 2021—Vanderbilt epidemiologists conducted in-depth whole genome sequencing of breast cancer risk genes in Black women, who die at higher rates and have more aggressive disease, to discover mutations that may improve testing and treatment selection.

Read more


Novel immunotherapy shows robust response for multiple myeloma

Sep. 10, 2021—Vanderbilt research found that a novel immunotherapy demonstrated robust effectiveness in treating relapsed or refractory multiple myeloma.

Read more


Discovery offers insight for development of cancer therapies targeting mutant p53

Sep. 2, 2021—Vanderbilt researchers have discovered that aneuploidy (an abnormal number of chromosomes) drives malignant phenotypes in cells expressing mutant p53, a tumor suppressor protein that is mutated in more than half of all human cancers.

Read more


Expression atlas for cell regulators

Aug. 19, 2021—Vanderbilt researchers report a comprehensive tissue-specific atlas of protein and mRNA expression for p63 and p73, members of the p53 family signaling network that is the most frequent target of mutations in human cancers.

Read more


Park named to new role as deputy director of Vanderbilt-Ingram Cancer Center

Aug. 19, 2021—Ben Ho Park, MD, PhD, Cornelius Abernathy Professor of Medicine, has been named deputy director of Vanderbilt-Ingram Cancer Center (VICC).

Read more


Supporting ovarian cancer research

Aug. 19, 2021—Rocker George Thorogood recently made a donation to Vanderbilt-Ingram Cancer Center (VICC) from the Marla Thorogood Memorial Fund for Ovarian Cancer Research.

Read more


Jackson elected fellow of American Association of Nurse Practitioners

Aug. 19, 2021—Heather Jackson, PhD, APRN, FNP-BC, NEA-BC, administrative director of Advanced Practice for Vanderbilt-Ingram Cancer Center (VICC), has been elected a fellow of the American Association of Nurse Practitioners (FAANP).

Read more


New Clinician Spotlight: Sonya Reid

Aug. 5, 2021—Sonya Reid, MD, MPH, assistant professor of Medicine in the Division of Hematology Oncology, is a member of the Vanderbilt-Ingram Cancer Center Breast Cancer Research Program and sees patients at Vanderbilt Health One Hundred Oaks.

Read more


Clinical trial to test immunotherapy for rectal cancer

Aug. 5, 2021—A new clinical trial seeks to determine whether immunotherapy in combination with short-course radiation followed by surgical resection could be a curative treatment for locally advanced rectal cancer.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more